Sinopharm To Restructure Xinjiang Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
Sinopharm has agreed to acquire Xinjiang Pharmaceutical Group, part of State-owned Assets Supervision and Administration Commission of Xinjiang Autonomous Region. Sinopharm plans to strengthen Xinjiang Pharmaceutical into a more competitive drug corporation in Northwest China by pumping in funds as well as providing support such as technology, management and training. With its edge in specialized ethnic medicine, Xinjiang Pharmaceutical accounts for half of the region's pharmaceutical distribution business. Sinopharm has been seeking pharmaceutical firms with good value in its bid to further reinforce its top position in the industry. (Click here for more - Chinese Language)
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.